nodes	percent_of_prediction	percent_of_DWPC	metapath
Ofloxacin—TOP2A—Mitoxantrone—multiple sclerosis	0.282	0.436	CbGbCtD
Ofloxacin—ABCC1—Mitoxantrone—multiple sclerosis	0.156	0.242	CbGbCtD
Ofloxacin—ABCC1—Methotrexate—multiple sclerosis	0.065	0.101	CbGbCtD
Ofloxacin—ABCC2—Dexamethasone—multiple sclerosis	0.0599	0.0927	CbGbCtD
Ofloxacin—ABCC2—Methotrexate—multiple sclerosis	0.0481	0.0745	CbGbCtD
Ofloxacin—SLC22A6—Methotrexate—multiple sclerosis	0.0352	0.0545	CbGbCtD
Ofloxacin—TOP2A—Floxuridine—Cladribine—multiple sclerosis	0.00157	0.378	CbGdCrCtD
Ofloxacin—TOP2A—Clofarabine—Cladribine—multiple sclerosis	0.0011	0.265	CbGdCrCtD
Ofloxacin—TOP2A—Azacitidine—Cladribine—multiple sclerosis	0.000671	0.161	CbGdCrCtD
Ofloxacin—TOP2A—Methyltestosterone—Prednisone—multiple sclerosis	0.000411	0.0989	CbGdCrCtD
Ofloxacin—TOP2A—Methyltestosterone—Prednisolone—multiple sclerosis	0.000401	0.0966	CbGdCrCtD
Ofloxacin—ABCC1—S1P1 pathway—S1PR1—multiple sclerosis	0.000204	0.0687	CbGpPWpGaD
Ofloxacin—ABCC1—Sphingosine 1-phosphate (S1P) pathway—S1PR1—multiple sclerosis	0.000189	0.0634	CbGpPWpGaD
Ofloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000138	0.0464	CbGpPWpGaD
Ofloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000138	0.0464	CbGpPWpGaD
Ofloxacin—ABCC2—Irinotecan Pathway—BCHE—multiple sclerosis	0.000122	0.0411	CbGpPWpGaD
Ofloxacin—ABCC1—Irinotecan Pathway—BCHE—multiple sclerosis	0.000121	0.0406	CbGpPWpGaD
Ofloxacin—Tachycardia—Triamcinolone—multiple sclerosis	0.000119	0.000342	CcSEcCtD
Ofloxacin—Mental disorder—Prednisone—multiple sclerosis	0.000119	0.000342	CcSEcCtD
Ofloxacin—Nausea—Azathioprine—multiple sclerosis	0.000119	0.000342	CcSEcCtD
Ofloxacin—Tachycardia—Methylprednisolone—multiple sclerosis	0.000119	0.000342	CcSEcCtD
Ofloxacin—Skin disorder—Methylprednisolone—multiple sclerosis	0.000118	0.00034	CcSEcCtD
Ofloxacin—Malnutrition—Prednisone—multiple sclerosis	0.000118	0.00034	CcSEcCtD
Ofloxacin—Erythema—Prednisone—multiple sclerosis	0.000118	0.00034	CcSEcCtD
Ofloxacin—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000118	0.000339	CcSEcCtD
Ofloxacin—Agranulocytosis—Methotrexate—multiple sclerosis	0.000118	0.000339	CcSEcCtD
Ofloxacin—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000117	0.000338	CcSEcCtD
Ofloxacin—Hypertension—Dexamethasone—multiple sclerosis	0.000117	0.000337	CcSEcCtD
Ofloxacin—Hypertension—Betamethasone—multiple sclerosis	0.000117	0.000337	CcSEcCtD
Ofloxacin—Asthenia—Mitoxantrone—multiple sclerosis	0.000116	0.000334	CcSEcCtD
Ofloxacin—Myalgia—Betamethasone—multiple sclerosis	0.000115	0.000332	CcSEcCtD
Ofloxacin—Myalgia—Dexamethasone—multiple sclerosis	0.000115	0.000332	CcSEcCtD
Ofloxacin—Anxiety—Betamethasone—multiple sclerosis	0.000115	0.000331	CcSEcCtD
Ofloxacin—Anxiety—Dexamethasone—multiple sclerosis	0.000115	0.000331	CcSEcCtD
Ofloxacin—Discomfort—Dexamethasone—multiple sclerosis	0.000114	0.000328	CcSEcCtD
Ofloxacin—Discomfort—Betamethasone—multiple sclerosis	0.000114	0.000328	CcSEcCtD
Ofloxacin—Haemoglobin—Methotrexate—multiple sclerosis	0.000114	0.000328	CcSEcCtD
Ofloxacin—Hypotension—Methylprednisolone—multiple sclerosis	0.000113	0.000327	CcSEcCtD
Ofloxacin—Pain—Prednisolone—multiple sclerosis	0.000113	0.000326	CcSEcCtD
Ofloxacin—Haemorrhage—Methotrexate—multiple sclerosis	0.000113	0.000326	CcSEcCtD
Ofloxacin—Hepatitis—Methotrexate—multiple sclerosis	0.000113	0.000326	CcSEcCtD
Ofloxacin—Pharyngitis—Methotrexate—multiple sclerosis	0.000112	0.000324	CcSEcCtD
Ofloxacin—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000112	0.000322	CcSEcCtD
Ofloxacin—Vision blurred—Prednisone—multiple sclerosis	0.000111	0.00032	CcSEcCtD
Ofloxacin—Urethral disorder—Methotrexate—multiple sclerosis	0.000111	0.00032	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000111	0.00032	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000111	0.000319	CcSEcCtD
Ofloxacin—Oedema—Betamethasone—multiple sclerosis	0.00011	0.000318	CcSEcCtD
Ofloxacin—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00011	0.000318	CcSEcCtD
Ofloxacin—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00011	0.000318	CcSEcCtD
Ofloxacin—Oedema—Dexamethasone—multiple sclerosis	0.00011	0.000318	CcSEcCtD
Ofloxacin—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00011	0.000318	CcSEcCtD
Ofloxacin—Insomnia—Triamcinolone—multiple sclerosis	0.00011	0.000317	CcSEcCtD
Ofloxacin—Insomnia—Methylprednisolone—multiple sclerosis	0.00011	0.000317	CcSEcCtD
Ofloxacin—Infection—Dexamethasone—multiple sclerosis	0.00011	0.000316	CcSEcCtD
Ofloxacin—Infection—Betamethasone—multiple sclerosis	0.00011	0.000316	CcSEcCtD
Ofloxacin—Ill-defined disorder—Prednisone—multiple sclerosis	0.000109	0.000315	CcSEcCtD
Ofloxacin—Paraesthesia—Triamcinolone—multiple sclerosis	0.000109	0.000315	CcSEcCtD
Ofloxacin—Feeling abnormal—Prednisolone—multiple sclerosis	0.000109	0.000314	CcSEcCtD
Ofloxacin—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000109	0.000314	CcSEcCtD
Ofloxacin—Visual impairment—Methotrexate—multiple sclerosis	0.000109	0.000314	CcSEcCtD
Ofloxacin—Anaemia—Prednisone—multiple sclerosis	0.000109	0.000314	CcSEcCtD
Ofloxacin—Shock—Dexamethasone—multiple sclerosis	0.000109	0.000313	CcSEcCtD
Ofloxacin—Shock—Betamethasone—multiple sclerosis	0.000109	0.000313	CcSEcCtD
Ofloxacin—Dyspnoea—Triamcinolone—multiple sclerosis	0.000109	0.000313	CcSEcCtD
Ofloxacin—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000108	0.000312	CcSEcCtD
Ofloxacin—Nervous system disorder—Betamethasone—multiple sclerosis	0.000108	0.000312	CcSEcCtD
Ofloxacin—Agitation—Prednisone—multiple sclerosis	0.000108	0.000312	CcSEcCtD
Ofloxacin—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000108	0.000312	CcSEcCtD
Ofloxacin—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000108	0.000312	CcSEcCtD
Ofloxacin—Tachycardia—Betamethasone—multiple sclerosis	0.000108	0.000311	CcSEcCtD
Ofloxacin—Tachycardia—Dexamethasone—multiple sclerosis	0.000108	0.000311	CcSEcCtD
Ofloxacin—Angioedema—Prednisone—multiple sclerosis	0.000108	0.00031	CcSEcCtD
Ofloxacin—Dyspepsia—Triamcinolone—multiple sclerosis	0.000107	0.000309	CcSEcCtD
Ofloxacin—Erythema multiforme—Methotrexate—multiple sclerosis	0.000107	0.000308	CcSEcCtD
Ofloxacin—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000107	0.000308	CcSEcCtD
Ofloxacin—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000107	0.000308	CcSEcCtD
Ofloxacin—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000107	0.000308	CcSEcCtD
Ofloxacin—Malaise—Prednisone—multiple sclerosis	0.000106	0.000306	CcSEcCtD
Ofloxacin—Vertigo—Prednisone—multiple sclerosis	0.000106	0.000305	CcSEcCtD
Ofloxacin—Eye disorder—Methotrexate—multiple sclerosis	0.000106	0.000305	CcSEcCtD
Ofloxacin—Syncope—Prednisone—multiple sclerosis	0.000106	0.000305	CcSEcCtD
Ofloxacin—Tinnitus—Methotrexate—multiple sclerosis	0.000105	0.000304	CcSEcCtD
Ofloxacin—Anorexia—Betamethasone—multiple sclerosis	0.000105	0.000303	CcSEcCtD
Ofloxacin—Anorexia—Dexamethasone—multiple sclerosis	0.000105	0.000303	CcSEcCtD
Ofloxacin—Urticaria—Prednisolone—multiple sclerosis	0.000105	0.000303	CcSEcCtD
Ofloxacin—Cardiac disorder—Methotrexate—multiple sclerosis	0.000105	0.000303	CcSEcCtD
Ofloxacin—Fatigue—Triamcinolone—multiple sclerosis	0.000105	0.000302	CcSEcCtD
Ofloxacin—Fatigue—Methylprednisolone—multiple sclerosis	0.000105	0.000302	CcSEcCtD
Ofloxacin—Pain—Triamcinolone—multiple sclerosis	0.000104	0.0003	CcSEcCtD
Ofloxacin—Loss of consciousness—Prednisone—multiple sclerosis	0.000104	0.000299	CcSEcCtD
Ofloxacin—Hypotension—Dexamethasone—multiple sclerosis	0.000103	0.000297	CcSEcCtD
Ofloxacin—Hypotension—Betamethasone—multiple sclerosis	0.000103	0.000297	CcSEcCtD
Ofloxacin—Angiopathy—Methotrexate—multiple sclerosis	0.000103	0.000296	CcSEcCtD
Ofloxacin—Vomiting—Mitoxantrone—multiple sclerosis	0.000103	0.000296	CcSEcCtD
Ofloxacin—Immune system disorder—Methotrexate—multiple sclerosis	0.000102	0.000295	CcSEcCtD
Ofloxacin—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000102	0.000294	CcSEcCtD
Ofloxacin—Hypertension—Prednisone—multiple sclerosis	0.000102	0.000293	CcSEcCtD
Ofloxacin—Rash—Mitoxantrone—multiple sclerosis	0.000102	0.000293	CcSEcCtD
Ofloxacin—Dermatitis—Mitoxantrone—multiple sclerosis	0.000102	0.000293	CcSEcCtD
Ofloxacin—Chills—Methotrexate—multiple sclerosis	0.000102	0.000293	CcSEcCtD
Ofloxacin—Headache—Mitoxantrone—multiple sclerosis	0.000101	0.000291	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000101	0.00029	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000101	0.00029	CcSEcCtD
Ofloxacin—Arthralgia—Prednisone—multiple sclerosis	0.0001	0.000289	CcSEcCtD
Ofloxacin—Myalgia—Prednisone—multiple sclerosis	0.0001	0.000289	CcSEcCtD
Ofloxacin—Feeling abnormal—Triamcinolone—multiple sclerosis	0.0001	0.000289	CcSEcCtD
Ofloxacin—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.0001	0.000288	CcSEcCtD
Ofloxacin—Anxiety—Prednisone—multiple sclerosis	0.0001	0.000288	CcSEcCtD
Ofloxacin—Alopecia—Methotrexate—multiple sclerosis	0.0001	0.000288	CcSEcCtD
Ofloxacin—Insomnia—Betamethasone—multiple sclerosis	9.99e-05	0.000288	CcSEcCtD
Ofloxacin—Insomnia—Dexamethasone—multiple sclerosis	9.99e-05	0.000288	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	9.96e-05	0.000287	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	9.93e-05	0.000286	CcSEcCtD
Ofloxacin—Paraesthesia—Betamethasone—multiple sclerosis	9.92e-05	0.000286	CcSEcCtD
Ofloxacin—Paraesthesia—Dexamethasone—multiple sclerosis	9.92e-05	0.000286	CcSEcCtD
Ofloxacin—Discomfort—Prednisone—multiple sclerosis	9.91e-05	0.000286	CcSEcCtD
Ofloxacin—Mental disorder—Methotrexate—multiple sclerosis	9.91e-05	0.000286	CcSEcCtD
Ofloxacin—Malnutrition—Methotrexate—multiple sclerosis	9.85e-05	0.000284	CcSEcCtD
Ofloxacin—Erythema—Methotrexate—multiple sclerosis	9.85e-05	0.000284	CcSEcCtD
Ofloxacin—Hypersensitivity—Prednisolone—multiple sclerosis	9.75e-05	0.000281	CcSEcCtD
Ofloxacin—Dyspepsia—Dexamethasone—multiple sclerosis	9.72e-05	0.00028	CcSEcCtD
Ofloxacin—Dyspepsia—Betamethasone—multiple sclerosis	9.72e-05	0.00028	CcSEcCtD
Ofloxacin—Urticaria—Triamcinolone—multiple sclerosis	9.67e-05	0.000279	CcSEcCtD
Ofloxacin—Urticaria—Methylprednisolone—multiple sclerosis	9.65e-05	0.000278	CcSEcCtD
Ofloxacin—Dysgeusia—Methotrexate—multiple sclerosis	9.64e-05	0.000278	CcSEcCtD
Ofloxacin—Body temperature increased—Triamcinolone—multiple sclerosis	9.62e-05	0.000277	CcSEcCtD
Ofloxacin—Anaphylactic shock—Prednisone—multiple sclerosis	9.62e-05	0.000277	CcSEcCtD
Ofloxacin—Oedema—Prednisone—multiple sclerosis	9.62e-05	0.000277	CcSEcCtD
Ofloxacin—Abdominal pain—Methylprednisolone—multiple sclerosis	9.6e-05	0.000277	CcSEcCtD
Ofloxacin—Decreased appetite—Dexamethasone—multiple sclerosis	9.6e-05	0.000277	CcSEcCtD
Ofloxacin—Decreased appetite—Betamethasone—multiple sclerosis	9.6e-05	0.000277	CcSEcCtD
Ofloxacin—Nausea—Mitoxantrone—multiple sclerosis	9.58e-05	0.000276	CcSEcCtD
Ofloxacin—Infection—Prednisone—multiple sclerosis	9.55e-05	0.000275	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Betamethasone—multiple sclerosis	9.53e-05	0.000275	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	9.53e-05	0.000275	CcSEcCtD
Ofloxacin—Back pain—Methotrexate—multiple sclerosis	9.53e-05	0.000275	CcSEcCtD
Ofloxacin—Fatigue—Betamethasone—multiple sclerosis	9.52e-05	0.000274	CcSEcCtD
Ofloxacin—Fatigue—Dexamethasone—multiple sclerosis	9.52e-05	0.000274	CcSEcCtD
Ofloxacin—Shock—Prednisone—multiple sclerosis	9.46e-05	0.000273	CcSEcCtD
Ofloxacin—Pain—Dexamethasone—multiple sclerosis	9.44e-05	0.000272	CcSEcCtD
Ofloxacin—Pain—Betamethasone—multiple sclerosis	9.44e-05	0.000272	CcSEcCtD
Ofloxacin—Nervous system disorder—Prednisone—multiple sclerosis	9.43e-05	0.000272	CcSEcCtD
Ofloxacin—Tachycardia—Prednisone—multiple sclerosis	9.39e-05	0.000271	CcSEcCtD
Ofloxacin—Skin disorder—Prednisone—multiple sclerosis	9.34e-05	0.000269	CcSEcCtD
Ofloxacin—Hyperhidrosis—Prednisone—multiple sclerosis	9.3e-05	0.000268	CcSEcCtD
Ofloxacin—Vision blurred—Methotrexate—multiple sclerosis	9.28e-05	0.000268	CcSEcCtD
Ofloxacin—Anorexia—Prednisone—multiple sclerosis	9.17e-05	0.000264	CcSEcCtD
Ofloxacin—Ill-defined disorder—Methotrexate—multiple sclerosis	9.14e-05	0.000263	CcSEcCtD
Ofloxacin—Anaemia—Methotrexate—multiple sclerosis	9.1e-05	0.000262	CcSEcCtD
Ofloxacin—Feeling abnormal—Dexamethasone—multiple sclerosis	9.1e-05	0.000262	CcSEcCtD
Ofloxacin—Feeling abnormal—Betamethasone—multiple sclerosis	9.1e-05	0.000262	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	9.03e-05	0.00026	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Betamethasone—multiple sclerosis	9.03e-05	0.00026	CcSEcCtD
Ofloxacin—Hypersensitivity—Triamcinolone—multiple sclerosis	8.97e-05	0.000258	CcSEcCtD
Ofloxacin—Hypersensitivity—Methylprednisolone—multiple sclerosis	8.95e-05	0.000258	CcSEcCtD
Ofloxacin—Malaise—Methotrexate—multiple sclerosis	8.88e-05	0.000256	CcSEcCtD
Ofloxacin—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	8.85e-05	0.0298	CbGpPWpGaD
Ofloxacin—Vertigo—Methotrexate—multiple sclerosis	8.85e-05	0.000255	CcSEcCtD
Ofloxacin—Leukopenia—Methotrexate—multiple sclerosis	8.82e-05	0.000254	CcSEcCtD
Ofloxacin—Urticaria—Dexamethasone—multiple sclerosis	8.77e-05	0.000253	CcSEcCtD
Ofloxacin—Urticaria—Betamethasone—multiple sclerosis	8.77e-05	0.000253	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	8.76e-05	0.000253	CcSEcCtD
Ofloxacin—Dizziness—Prednisolone—multiple sclerosis	8.75e-05	0.000252	CcSEcCtD
Ofloxacin—Asthenia—Triamcinolone—multiple sclerosis	8.73e-05	0.000252	CcSEcCtD
Ofloxacin—Abdominal pain—Betamethasone—multiple sclerosis	8.73e-05	0.000252	CcSEcCtD
Ofloxacin—Abdominal pain—Dexamethasone—multiple sclerosis	8.73e-05	0.000252	CcSEcCtD
Ofloxacin—Body temperature increased—Dexamethasone—multiple sclerosis	8.73e-05	0.000252	CcSEcCtD
Ofloxacin—Body temperature increased—Betamethasone—multiple sclerosis	8.73e-05	0.000252	CcSEcCtD
Ofloxacin—Asthenia—Methylprednisolone—multiple sclerosis	8.71e-05	0.000251	CcSEcCtD
Ofloxacin—Insomnia—Prednisone—multiple sclerosis	8.7e-05	0.000251	CcSEcCtD
Ofloxacin—Paraesthesia—Prednisone—multiple sclerosis	8.64e-05	0.000249	CcSEcCtD
Ofloxacin—Pruritus—Triamcinolone—multiple sclerosis	8.61e-05	0.000248	CcSEcCtD
Ofloxacin—Cough—Methotrexate—multiple sclerosis	8.59e-05	0.000248	CcSEcCtD
Ofloxacin—Pruritus—Methylprednisolone—multiple sclerosis	8.59e-05	0.000248	CcSEcCtD
Ofloxacin—Dyspepsia—Prednisone—multiple sclerosis	8.47e-05	0.000244	CcSEcCtD
Ofloxacin—Arthralgia—Methotrexate—multiple sclerosis	8.38e-05	0.000242	CcSEcCtD
Ofloxacin—Myalgia—Methotrexate—multiple sclerosis	8.38e-05	0.000242	CcSEcCtD
Ofloxacin—Chest pain—Methotrexate—multiple sclerosis	8.38e-05	0.000242	CcSEcCtD
Ofloxacin—Decreased appetite—Prednisone—multiple sclerosis	8.36e-05	0.000241	CcSEcCtD
Ofloxacin—Rash—Prednisolone—multiple sclerosis	8.34e-05	0.000241	CcSEcCtD
Ofloxacin—Dermatitis—Prednisolone—multiple sclerosis	8.34e-05	0.00024	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	8.33e-05	0.00024	CcSEcCtD
Ofloxacin—Diarrhoea—Methylprednisolone—multiple sclerosis	8.31e-05	0.00024	CcSEcCtD
Ofloxacin—Fatigue—Prednisone—multiple sclerosis	8.29e-05	0.000239	CcSEcCtD
Ofloxacin—Headache—Prednisolone—multiple sclerosis	8.29e-05	0.000239	CcSEcCtD
Ofloxacin—Discomfort—Methotrexate—multiple sclerosis	8.28e-05	0.000239	CcSEcCtD
Ofloxacin—Constipation—Prednisone—multiple sclerosis	8.22e-05	0.000237	CcSEcCtD
Ofloxacin—Confusional state—Methotrexate—multiple sclerosis	8.1e-05	0.000234	CcSEcCtD
Ofloxacin—Dizziness—Triamcinolone—multiple sclerosis	8.05e-05	0.000232	CcSEcCtD
Ofloxacin—Anaphylactic shock—Methotrexate—multiple sclerosis	8.04e-05	0.000232	CcSEcCtD
Ofloxacin—Dizziness—Methylprednisolone—multiple sclerosis	8.03e-05	0.000231	CcSEcCtD
Ofloxacin—Infection—Methotrexate—multiple sclerosis	7.98e-05	0.00023	CcSEcCtD
Ofloxacin—Feeling abnormal—Prednisone—multiple sclerosis	7.93e-05	0.000228	CcSEcCtD
Ofloxacin—Asthenia—Betamethasone—multiple sclerosis	7.92e-05	0.000228	CcSEcCtD
Ofloxacin—Asthenia—Dexamethasone—multiple sclerosis	7.92e-05	0.000228	CcSEcCtD
Ofloxacin—Nervous system disorder—Methotrexate—multiple sclerosis	7.88e-05	0.000227	CcSEcCtD
Ofloxacin—Thrombocytopenia—Methotrexate—multiple sclerosis	7.87e-05	0.000227	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Prednisone—multiple sclerosis	7.86e-05	0.000227	CcSEcCtD
Ofloxacin—Nausea—Prednisolone—multiple sclerosis	7.86e-05	0.000227	CcSEcCtD
Ofloxacin—ABCC2—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	7.86e-05	0.0264	CbGpPWpGaD
Ofloxacin—Pruritus—Betamethasone—multiple sclerosis	7.81e-05	0.000225	CcSEcCtD
Ofloxacin—Pruritus—Dexamethasone—multiple sclerosis	7.81e-05	0.000225	CcSEcCtD
Ofloxacin—Skin disorder—Methotrexate—multiple sclerosis	7.81e-05	0.000225	CcSEcCtD
Ofloxacin—Hyperhidrosis—Methotrexate—multiple sclerosis	7.77e-05	0.000224	CcSEcCtD
Ofloxacin—Vomiting—Triamcinolone—multiple sclerosis	7.74e-05	0.000223	CcSEcCtD
Ofloxacin—Vomiting—Methylprednisolone—multiple sclerosis	7.72e-05	0.000223	CcSEcCtD
Ofloxacin—Rash—Triamcinolone—multiple sclerosis	7.67e-05	0.000221	CcSEcCtD
Ofloxacin—Dermatitis—Triamcinolone—multiple sclerosis	7.67e-05	0.000221	CcSEcCtD
Ofloxacin—Anorexia—Methotrexate—multiple sclerosis	7.66e-05	0.000221	CcSEcCtD
Ofloxacin—Rash—Methylprednisolone—multiple sclerosis	7.66e-05	0.000221	CcSEcCtD
Ofloxacin—Dermatitis—Methylprednisolone—multiple sclerosis	7.65e-05	0.000221	CcSEcCtD
Ofloxacin—Urticaria—Prednisone—multiple sclerosis	7.64e-05	0.00022	CcSEcCtD
Ofloxacin—Headache—Triamcinolone—multiple sclerosis	7.62e-05	0.00022	CcSEcCtD
Ofloxacin—Headache—Methylprednisolone—multiple sclerosis	7.61e-05	0.000219	CcSEcCtD
Ofloxacin—Body temperature increased—Prednisone—multiple sclerosis	7.6e-05	0.000219	CcSEcCtD
Ofloxacin—Abdominal pain—Prednisone—multiple sclerosis	7.6e-05	0.000219	CcSEcCtD
Ofloxacin—Diarrhoea—Betamethasone—multiple sclerosis	7.56e-05	0.000218	CcSEcCtD
Ofloxacin—Diarrhoea—Dexamethasone—multiple sclerosis	7.56e-05	0.000218	CcSEcCtD
Ofloxacin—Hypotension—Methotrexate—multiple sclerosis	7.51e-05	0.000216	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	7.32e-05	0.000211	CcSEcCtD
Ofloxacin—Dizziness—Dexamethasone—multiple sclerosis	7.3e-05	0.00021	CcSEcCtD
Ofloxacin—Dizziness—Betamethasone—multiple sclerosis	7.3e-05	0.00021	CcSEcCtD
Ofloxacin—Insomnia—Methotrexate—multiple sclerosis	7.27e-05	0.00021	CcSEcCtD
Ofloxacin—Nausea—Triamcinolone—multiple sclerosis	7.23e-05	0.000208	CcSEcCtD
Ofloxacin—Paraesthesia—Methotrexate—multiple sclerosis	7.22e-05	0.000208	CcSEcCtD
Ofloxacin—Nausea—Methylprednisolone—multiple sclerosis	7.21e-05	0.000208	CcSEcCtD
Ofloxacin—Dyspnoea—Methotrexate—multiple sclerosis	7.17e-05	0.000207	CcSEcCtD
Ofloxacin—Somnolence—Methotrexate—multiple sclerosis	7.15e-05	0.000206	CcSEcCtD
Ofloxacin—Hypersensitivity—Prednisone—multiple sclerosis	7.09e-05	0.000204	CcSEcCtD
Ofloxacin—Dyspepsia—Methotrexate—multiple sclerosis	7.07e-05	0.000204	CcSEcCtD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RRM1—multiple sclerosis	7.04e-05	0.0237	CbGpPWpGaD
Ofloxacin—Vomiting—Dexamethasone—multiple sclerosis	7.02e-05	0.000202	CcSEcCtD
Ofloxacin—Vomiting—Betamethasone—multiple sclerosis	7.02e-05	0.000202	CcSEcCtD
Ofloxacin—Decreased appetite—Methotrexate—multiple sclerosis	6.99e-05	0.000201	CcSEcCtD
Ofloxacin—Rash—Dexamethasone—multiple sclerosis	6.96e-05	0.000201	CcSEcCtD
Ofloxacin—Rash—Betamethasone—multiple sclerosis	6.96e-05	0.000201	CcSEcCtD
Ofloxacin—Dermatitis—Betamethasone—multiple sclerosis	6.96e-05	0.000201	CcSEcCtD
Ofloxacin—Dermatitis—Dexamethasone—multiple sclerosis	6.96e-05	0.000201	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Methotrexate—multiple sclerosis	6.94e-05	0.0002	CcSEcCtD
Ofloxacin—Fatigue—Methotrexate—multiple sclerosis	6.93e-05	0.0002	CcSEcCtD
Ofloxacin—Headache—Betamethasone—multiple sclerosis	6.92e-05	0.000199	CcSEcCtD
Ofloxacin—Headache—Dexamethasone—multiple sclerosis	6.92e-05	0.000199	CcSEcCtD
Ofloxacin—Asthenia—Prednisone—multiple sclerosis	6.9e-05	0.000199	CcSEcCtD
Ofloxacin—Pain—Methotrexate—multiple sclerosis	6.87e-05	0.000198	CcSEcCtD
Ofloxacin—Pruritus—Prednisone—multiple sclerosis	6.8e-05	0.000196	CcSEcCtD
Ofloxacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	6.65e-05	0.0224	CbGpPWpGaD
Ofloxacin—Feeling abnormal—Methotrexate—multiple sclerosis	6.62e-05	0.000191	CcSEcCtD
Ofloxacin—Diarrhoea—Prednisone—multiple sclerosis	6.58e-05	0.00019	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Methotrexate—multiple sclerosis	6.57e-05	0.000189	CcSEcCtD
Ofloxacin—Nausea—Betamethasone—multiple sclerosis	6.56e-05	0.000189	CcSEcCtD
Ofloxacin—Nausea—Dexamethasone—multiple sclerosis	6.56e-05	0.000189	CcSEcCtD
Ofloxacin—Urticaria—Methotrexate—multiple sclerosis	6.39e-05	0.000184	CcSEcCtD
Ofloxacin—Dizziness—Prednisone—multiple sclerosis	6.36e-05	0.000183	CcSEcCtD
Ofloxacin—Abdominal pain—Methotrexate—multiple sclerosis	6.35e-05	0.000183	CcSEcCtD
Ofloxacin—Body temperature increased—Methotrexate—multiple sclerosis	6.35e-05	0.000183	CcSEcCtD
Ofloxacin—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	6.18e-05	0.0208	CbGpPWpGaD
Ofloxacin—Vomiting—Prednisone—multiple sclerosis	6.11e-05	0.000176	CcSEcCtD
Ofloxacin—Rash—Prednisone—multiple sclerosis	6.06e-05	0.000175	CcSEcCtD
Ofloxacin—Dermatitis—Prednisone—multiple sclerosis	6.06e-05	0.000175	CcSEcCtD
Ofloxacin—Headache—Prednisone—multiple sclerosis	6.02e-05	0.000174	CcSEcCtD
Ofloxacin—Hypersensitivity—Methotrexate—multiple sclerosis	5.92e-05	0.000171	CcSEcCtD
Ofloxacin—Asthenia—Methotrexate—multiple sclerosis	5.77e-05	0.000166	CcSEcCtD
Ofloxacin—Nausea—Prednisone—multiple sclerosis	5.71e-05	0.000165	CcSEcCtD
Ofloxacin—Pruritus—Methotrexate—multiple sclerosis	5.69e-05	0.000164	CcSEcCtD
Ofloxacin—Diarrhoea—Methotrexate—multiple sclerosis	5.5e-05	0.000159	CcSEcCtD
Ofloxacin—Dizziness—Methotrexate—multiple sclerosis	5.31e-05	0.000153	CcSEcCtD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	5.31e-05	0.0179	CbGpPWpGaD
Ofloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	5.18e-05	0.0174	CbGpPWpGaD
Ofloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	5.18e-05	0.0174	CbGpPWpGaD
Ofloxacin—Vomiting—Methotrexate—multiple sclerosis	5.11e-05	0.000147	CcSEcCtD
Ofloxacin—Rash—Methotrexate—multiple sclerosis	5.07e-05	0.000146	CcSEcCtD
Ofloxacin—Dermatitis—Methotrexate—multiple sclerosis	5.06e-05	0.000146	CcSEcCtD
Ofloxacin—Headache—Methotrexate—multiple sclerosis	5.04e-05	0.000145	CcSEcCtD
Ofloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	5.02e-05	0.0169	CbGpPWpGaD
Ofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—VDR—multiple sclerosis	4.98e-05	0.0167	CbGpPWpGaD
Ofloxacin—Nausea—Methotrexate—multiple sclerosis	4.77e-05	0.000138	CcSEcCtD
Ofloxacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	4.65e-05	0.0156	CbGpPWpGaD
Ofloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	4.51e-05	0.0152	CbGpPWpGaD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	4.02e-05	0.0135	CbGpPWpGaD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	3.99e-05	0.0134	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	3.75e-05	0.0126	CbGpPWpGaD
Ofloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	3.51e-05	0.0118	CbGpPWpGaD
Ofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	3.29e-05	0.0111	CbGpPWpGaD
Ofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	3.29e-05	0.0111	CbGpPWpGaD
Ofloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	3.25e-05	0.0109	CbGpPWpGaD
Ofloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	3.25e-05	0.0109	CbGpPWpGaD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	3.02e-05	0.0102	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	3.01e-05	0.0101	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	2.82e-05	0.00948	CbGpPWpGaD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	2.81e-05	0.00945	CbGpPWpGaD
Ofloxacin—ABCC1—S1P1 pathway—MAPK1—multiple sclerosis	2.76e-05	0.0093	CbGpPWpGaD
Ofloxacin—TOP2A—Gastric Cancer Network 2—MYC—multiple sclerosis	2.76e-05	0.00928	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.7e-05	0.00907	CbGpPWpGaD
Ofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	2.67e-05	0.00897	CbGpPWpGaD
Ofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	2.67e-05	0.00897	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	2.28e-05	0.00768	CbGpPWpGaD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	2.11e-05	0.00711	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	2.06e-05	0.00692	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.04e-05	0.00687	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.03e-05	0.00682	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	1.77e-05	0.00596	CbGpPWpGaD
Ofloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	1.69e-05	0.0057	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	1.65e-05	0.00556	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.62e-05	0.00543	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	1.59e-05	0.00536	CbGpPWpGaD
Ofloxacin—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	1.56e-05	0.00526	CbGpPWpGaD
Ofloxacin—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	1.54e-05	0.00518	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.54e-05	0.00517	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.53e-05	0.00515	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.48e-05	0.00499	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.46e-05	0.00493	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.43e-05	0.00482	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.43e-05	0.00482	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.43e-05	0.0048	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	1.42e-05	0.00476	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	1.42e-05	0.00476	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	1.41e-05	0.00476	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	1.4e-05	0.0047	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	1.4e-05	0.0047	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—FAS—multiple sclerosis	1.36e-05	0.00456	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.21e-05	0.00408	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	1.21e-05	0.00407	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.16e-05	0.0039	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.12e-05	0.00378	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.11e-05	0.00373	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.07e-05	0.00361	CbGpPWpGaD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.01e-05	0.0034	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	9.16e-06	0.00308	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SRM—multiple sclerosis	9.05e-06	0.00304	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.88e-06	0.00299	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.77e-06	0.00295	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—multiple sclerosis	8.5e-06	0.00286	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.1e-06	0.00273	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.85e-06	0.00264	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.75e-06	0.00261	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	7.61e-06	0.00256	CbGpPWpGaD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—ALB—multiple sclerosis	7.6e-06	0.00256	CbGpPWpGaD
Ofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.4e-06	0.00249	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—GPC5—multiple sclerosis	6.96e-06	0.00234	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	6.79e-06	0.00228	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	6.76e-06	0.00228	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	6.44e-06	0.00217	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	6.43e-06	0.00216	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYP27B1—multiple sclerosis	6.38e-06	0.00215	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYP24A1—multiple sclerosis	6.38e-06	0.00215	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	6.3e-06	0.00212	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.23e-06	0.0021	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	6e-06	0.00202	CbGpPWpGaD
Ofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6e-06	0.00202	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GPC5—multiple sclerosis	5.83e-06	0.00196	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	5.74e-06	0.00193	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—TGFB1—multiple sclerosis	5.58e-06	0.00188	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.44e-06	0.00183	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.44e-06	0.00183	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	5.29e-06	0.00178	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	5.28e-06	0.00178	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	5.17e-06	0.00174	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.14e-06	0.00173	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	4.93e-06	0.00166	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	4.93e-06	0.00166	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—RRM1—multiple sclerosis	4.83e-06	0.00163	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—IL6—multiple sclerosis	4.65e-06	0.00156	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—RPL5—multiple sclerosis	4.53e-06	0.00152	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SLC11A1—multiple sclerosis	4.34e-06	0.00146	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.86e-06	0.0013	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.75e-06	0.00126	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CD28—multiple sclerosis	3.46e-06	0.00117	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SRM—multiple sclerosis	3.44e-06	0.00116	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.22e-06	0.00108	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—POMC—multiple sclerosis	3.19e-06	0.00107	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—MYC—multiple sclerosis	3.12e-06	0.00105	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	3.05e-06	0.00103	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.94e-06	0.000988	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.92e-06	0.000981	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.82e-06	0.00095	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.79e-06	0.000939	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—MYC—multiple sclerosis	2.79e-06	0.000938	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—BCHE—multiple sclerosis	2.78e-06	0.000934	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—MAPK1—multiple sclerosis	2.73e-06	0.000918	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CD86—multiple sclerosis	2.47e-06	0.000831	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	2.42e-06	0.000815	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	2.42e-06	0.000815	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.37e-06	0.000796	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GPC5—multiple sclerosis	2.21e-06	0.000745	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CCR5—multiple sclerosis	2.19e-06	0.000737	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HLA-A—multiple sclerosis	2.14e-06	0.000718	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—APOE—multiple sclerosis	1.99e-06	0.000671	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.84e-06	0.000617	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CD80—multiple sclerosis	1.8e-06	0.000606	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—APOE—multiple sclerosis	1.67e-06	0.000562	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TYK2—multiple sclerosis	1.52e-06	0.000512	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—POMC—multiple sclerosis	1.43e-06	0.000483	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.42e-06	0.000479	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CD4—multiple sclerosis	1.38e-06	0.000463	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ALB—multiple sclerosis	1.31e-06	0.00044	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.22e-06	0.000412	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.12e-06	0.000375	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—STAT3—multiple sclerosis	1.07e-06	0.000358	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.05e-06	0.000355	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MYC—multiple sclerosis	9.9e-07	0.000333	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TGFB1—multiple sclerosis	9.88e-07	0.000332	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MAPK1—multiple sclerosis	9.69e-07	0.000326	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—IL6—multiple sclerosis	7.44e-07	0.00025	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—APOE—multiple sclerosis	6.34e-07	0.000213	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—POMC—multiple sclerosis	5.45e-07	0.000183	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ALB—multiple sclerosis	4.97e-07	0.000167	CbGpPWpGaD
